{
    "nct_id": "NCT04492800",
    "official_title": "A Hair Loss Prevention Study for Patients With Advanced Pancreatic Cancer Utilizing Scalp Cooling",
    "inclusion_criteria": "* Willing and able to provide written informed consent/assent for the trial\n* >18 years of age on day of signing informed consent\n* Diagnosis of pancreatic cancer and scheduled to receive treatment with a regimen containing nab-paclitaxel, gemcitabine and cisplatin\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Grade 1 alopecia\n* Existing history of scalp metastases or the presence of scalp metastases is suspected\n* No history of previous cancers within the past 5 years\n* CNS malignancies (either primary or metastatic)\n* Cold sensitivity, cold agglutinin disease, cryoglobulinemia, cryofibrinogenemia, cold migraine, cold urticaria, post-traumatic cold dystrophy\n* Imminent bone marrow ablation chemotherapy\n* Imminent skull radiation\n* Previously received or scheduled to undergo skull irradiation\n* Severe liver or renal disease from any etiology as patient may not be able to metabolize or clear the metabolites of the chemotherapeutic agent\n* Skin cancers including melanoma, squamous cell carcinoma and Merkel cell carcinoma\n* Small cell carcinoma of the lung\n* Solid tumors that have a high likelihood for metastasis in transit\n* Squamous cell carcinoma of the lung",
    "miscellaneous_criteria": ""
}